MetaCap

Quest Diagnostics Statistics

NYSE: DGXHealth CareMedical SpecialitiesUSD

258.28-0.81 (-0.31%)

At close: Nov 20, 4:01 PM ET · Delayed 15 min

Quest Diagnostics by the numbers

Quest Diagnostics has a market capitalization of $28.42 billion based on 110.02M shares outstanding. Its trailing P/E ratio is 25.7, below the 5-company peer median of 30.1, and its forward P/E is 21.6. The stock trades 6.0% above its 50-day average and 18.8% above its 200-day average.

Average daily trading volume is 1.03M shares, or about $266.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

DGX valuation vs. peer median

DGX compared with the median of 8 peer companies
MetricDGXPeer medianDifference
Market cap$28.42B$29.48B-4%
P/E (TTM)25.730.1-15%
Forward P/E21.619.6+10%
Avg. volume1.03M1.61M-36%

Peer median across 8 companies: ILMN, LH, CNC, GH, NTRA, MOH, HUM, HSIC.

Valuation

Market cap
$28.42B
Price / sales (latest FY)
2.58
EPS (TTM)
$10.04

Price and trading

Previous close
259.09
Open
262.00
Day range
257.56 – 262.96
52-week range
171.18 – 263.19
52-week change
+35.05%
Beta
—
Volume
1.37M

Dividends and events

Annual dividend
$3.38
Next earnings date
Oct 22, 2026

Additional statistics

Market Cap
28.42B
Pe
25.73
Forward Pe
21.55
Eps
10.04
Dividend Yield
133.00%
Dividend Rate
3.38
Week52 High
263.19
Week52 Low
171.18
Avg Volume
1.03M
Shares Outstanding
110.02M
Ma50
243.73
Ma200
217.49
Earnings Date
Oct 22, 2026
Pct From52w High
-1.87%
Pct From52w Low
50.88%

Related